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Background: Two atherosclerosis-susceptible and -resistant Japanese quail (Coturnix japonica) strains obtained by
divergent selection are commonly used as models to study atherosclerosis, but no genetic characterization of their
phenotypic differences has been reported so far. Our objective was to examine possible differences in the
expression of genes involved in cholesterol metabolism and transport in the liver between these two strains and to
evaluate the value of this model to analyze the gene system affecting cholesterol metabolism and transport.
Methods: A factorial study with both strains (atherosclerosis-susceptible versus atherosclerosis-resistant) and two
diets (control versus cholesterol) was carried out. The mRNA concentrations of four genes involved in cholesterol
biosynthesis (HMGCR, FDFT1, SQLE and DHCR7) and three genes in cholesterol transport (ABCG5, ABCG8 and APOA1)
were assayed using real-time quantitative PCR. Plasma lipids were also assayed.
Results: Expression of ABCG5 (control diet) and ABCG8 (regardless of dietary treatment) and expression of HMGCR,
FDFT1 and SQLE (regardless of dietary treatment) were significantly higher in the atherosclerosis-resistant than in the
atherosclerosis-susceptible strain. Plasma triglyceride and LDL levels, and LDL/HDL ratio were significantly higher in
the atherosclerosis-susceptible than in the atherosclerosis-resistant strain fed the cholesterol diet. In the
atherosclerosis-susceptible strain, ABCG5 expression regressed significantly and positively on plasma LDL level,
whereas DHCR7 and SQLE expression regressed significantly and negatively on plasma triglyceride level.
Conclusions: Our results provide support for the hypothesis that the atherosclerosis-resistant strain metabolizes and
excretes cholesterol faster than the atherosclerosis-susceptible strain. We have also demonstrated that these quail
strains are a useful model to study cholesterol metabolism and transport in relation with atherosclerosis.Background
Atherosclerosis is a complex pathological process that is
affected by both environmental and genetic factors; it is a
major cause of morbidity and mortality in industrialized
societies [1,2]. Although surgical and medical treatments
have progressed, current therapies that slow the formation
of atherosclerotic plaques are not totally successful [2].
Therefore, it is necessary to continue investigating the fun-
damental mechanisms that cause atherosclerosis to
develop more effective forms of treatment e.g. [3].* Correspondence: kmtc@mail.ubc.ca
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reproduction in any medium, provided the orJapanese quail (Coturnix japonica) was first used as a
research model for atherosclerosis in the early 1960s [4],
and since then, numerous studies have demonstrated the
value of this model to obtain information on the devel-
opment of hypercholesterolemia and atherosclerosis in
man. One reason why the Japanese quail is a good model
to study atherosclerosis is that it can develop “complex”
vascular lesions (focal haemorrhage, calcification and
fibrosis) that are very similar to lesions in man [5–7].
Divergent selection of Japanese quail for susceptibility
and resistance to atherosclerotic plaque formation
induced by dietary cholesterol have resulted in two
strains i.e. atherosclerosis-susceptible (SUS) and athero-
sclerosis-resistant (RES) strains that are valuable models.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Semi-synthetic diets
Ingredients (g/kg) Control diet Cholesterol diet
Soy protein flour (50% protein) 340 340
Corn starch 400 390
Limestone 50 50




Vitamin premix 5 5
D-L methionine 4 4
Choline chloride 3.8 3.8
Tallow 50 50
Vegetable oil 30 30
Cholesterol 0 5
Cholic acid 0 2.5
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plaques even when exposed to a 0.5% w/w cholesterol diet
[7]. Before selection, 8% of the males from a random-bred
foundation population developed atherosclerosis when fed
a high cholesterol diet (0.5% w/w) [5]. After divergent se-
lection during four generations, 80% of the SUS males as
compared to only 4% of the RES males developed athero-
sclerosis [5]. However, apart from the characterization of
certain physiological differences between these two strains,
no molecular characterization of the phenotypic differ-
ences has been carried out. Previous studies [5,8] have
shown that after cholesterol feeding, plasma cholesterol
levels remain high for a significantly longer time in the
SUS than in the RES males. In addition, SUS males have
fatty livers and higher amounts of liver cholesterol than
RES males. Shih et al. [5] hypothesized that the RES indivi-
duals were more resistant because “they metabolized and
excreted cholesterol faster than the SUS”. Therefore, in
our study, we have compared the expression of several
genes involved in cholesterol metabolism and transport in
the liver of SUS and RES males.
The mevalonate pathway (or HMG-CoA reductase path-
way) is an important component of the endogenous choles-
terol biosynthesis pathway [9] in the liver. During the
process of converting mevalonate to cholesterol and other
sterol isoprenoids, many important enzymes such as 3-
hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR
or HMG-CoA reductase), squalene synthase (FDFT1),
squalene expoxidase (SQLE), mevalonate kinase (MVK),
phosphomevalonate kinase (PMVK) and 7-dehydrocholes-
terol reductase (DHCR7) are involved in regulating the
overall process [9]. We examined the individual expression
of the following genes HMGCR, FDFT1, SQLE and DHCR7
by quantifying their mRNA levels in liver cells of SUS and
RES males.
ABCG5 and ABCG8, from the ATP binding cassette
(ABC) transporter family, are cholesterol excretion
transporters [3]. Apolipoprotein A1 (APOA1) is the
major protein component of HDL in plasma and is
believed to have a protective effect against atheroscler-
osis by participating in the reverse transport of hepatic
cholesterol from tissues to the bile for excretion
[10–12]. Therefore, we also included the genes of these
three proteins in our study.
Methods
Experimental birds
The SUS and RES quail stains were acquired by the
University of British Columbia (UBC) Quail Genetic
Resource Centre from the North Carolina State University
in 1989. Since then, they have undergone further divergent
selection for susceptibility and resistance to atherosclerotic
plaque formation induced by dietary cholesterol (0.5%w/w)
(KM Cheng, unpublished data).Experimental design
After hatching, both SUS (N= 50) and RES (N= 50)
males were fed a semi-synthetic diet (Table 1) prepared
by the feed mill at the Agriculture and Agri-Food
Canada Research Station at Agassiz, British Columbia,
according to the NRC nutrient requirement standards
recommended for quail (http://www.nap.edu/catalog/
2114.html). At six weeks of age, 13 birds (6 SUS and 7
RES) were euthanized and liver tissues were collected.
The remaining birds were divided into two dietary treat-
ment groups, fed either a regular synthetic diet or a syn-
thetic diet containing cholesterol (0.5% w/w) (Table 1)
for another six weeks (Table 2). At twelve weeks of age,
24 birds from each dietary treatment group were eutha-
nized and liver tissue samples were collected for further
analysis. This research was carried out with the approval
of the UBC Animal Care Committee, Certificate # A06-
1473.
Preparation of total RNA and synthesis of first-strand
cDNA
The birds were euthanized by decapitation. Livers were
then quickly removed, dissected and stored in RNAlater
reagent (Qiagen, Valencia, CA, USA) at −20°C until use.
Total RNA from liver cells was extracted using RNeasy
mini columns (Qiagen, Valencia, CA, USA). Concentra-
tion and purity were checked by spectrophotometer.
cDNA was synthesized using SuperScript™ ІІІ RT (200
units/μl) (Invitrogen Corporation, Carlsbad, CA, USA) at
50°C using Oligo (dT)18 primers (Fermentas Inc., Glen
Burnie, MD, USA) according to the manufacturer's
instructions. Each 38 μl reaction volume contained 5 μg of
total RNA, 1 μl Oligo (dT)18 primers (100 mM), 2 μl
dNTP (10 mM) (Fermentas Inc., Glen Burnie, MD, USA),
Table 2 Dietary treatments (between weeks 7 and 12)
and number of birds analyzed
Diet treatments SUS RES
Regular diet 6 males 6 males
Cholesterol diet (0.5% w/w) 6 males 6 males
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SuperScript™ ІІІ RT. One μl of RiboLock™ RNase Inhibitor
(40 U/μl) (Fermentas Inc., Glen Burnie, MD, USA) was
added to each reaction mixture in order to inhibit RNA
degradation during reverse transcription. The first-strand
cDNA was stored at −20° C for future real-time PCR.
Primer design
Primer pairs for each gene selected were designed using
either Japanese quail (Coturnix japonica) or chicken
(Gallus gallus) sequence information from the National
Center for Biotechnology Information (NCBI, www.ncbi.
nlm.nih.gov) GenBank database. The glyceraldehyde
3-phosphate dehydrogenase (GAPDH) gene was used as
an internal control [13]. Real-time PCR primers were
designed using Primer Express version 2.0.0 (Applied
Biosystems, Foster City, CA, USA) and were ordered
from IDT (Integrated DNA technologies, Coralville, IA,
USA). Primer information is shown in Table 3.
Real-time PCR
An aliquot of the purified first strand cDNA templates was
used to prepare the standard curve cDNA template mix-
ture (calibrated sample), while the remainder was dilutedTable 3 Real-time PCR primer combinations
Primer name Gene ID Species
GAPDH Z19086 C. coturnix
HMGCR NM_204485 G. gallus
FDFT1 NM_001039294 G. gallus
SQLE NM_001030953 G. gallus
DHCR7 XM_420914 G. gallus
ABCG5 XM_419457 G. gallus
ABCG8 XM_419458 G. gallus
APOA1 D85133 C. coturnixto half the concentration for the real-time PCR. Real-time
PCR was performed using an ABI Prism 7000 (Applied
Biosystems, Foster City, CA, USA). Each sample was run
in duplicate. The PCR was carried out in a reaction volume
of 22 μl, containing 2 μl cDNA template (diluted 1:1 in
water), 0.4 μl forward primer (10 μM), 0.4 μl reverse pri-
mer (10 μM) (Integrated DNA technologies, Coralville, IA)
and 10 μl SYBR Green universal PCR Master Mix (Applied
Biosystems, Foster City, CA, USA), and water was added
to a final volume of 22 μl. The following PCR conditions
were applied: 50° C for 2 min, 95° C for 10 min, and 40
cycles of denaturation at 95° C for 15 s and annealing and
extension at 60° C for 1 min. Fluorescence measurements
were recorded using SYBR as the reporter dye and the
results were normalized to the endogenous control,
GAPDH. A standard curve was produced for all primers
using serial dilutions of cDNA (2x, 1x, 1/2x, 1/4x and 1/8x).
The 2x mixture was prepared with the first-strand cDNA
products (which had twice the concentration of template
cDNA). Raw data analyses were done with the 7000 System
Software (Applied Biosystems, Foster City, CA, USA). Ex-
pression levels were quantified by comparing the results of
each real-time PCR to the standard curve produced by ser-
ial dilutions. Normalized mRNA levels were then calculated
as the ratio of the measured amount of target gene mRNA
to the amount of GAPDHmRNA.
Plasma lipid assays
Plasma samples (N= 56; including samples from birds
used for the real-time PCR analysis) from 6-week old
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RES/cholesterol) SUS and RES males fed both dietary
treatments were sent to the Department of Pathology and
Laboratory Medicine at St. Paul’s Hospital (Vancouver, BC)
and assayed for total cholesterol, HDL, and triglycerides
using enzymatic methods on an ADVIA 1650 Chemistry
System. HDL was assessed by the direct method without
precipitation of apolipoprotein B [14–16]. LDL values were
determined by Friedewald’s formula, using measured values
for total cholesterol, HDL and triglycerides [17,18].
Statistical analysis
Least squares analysis of variance was performed using
JMP 8.0 (SAS Institute, North Carolina, 2008). The statis-
tical model for mRNA levels was:
Yijkl ¼ μþ Si þ Dj þ Ak þ SDð Þij þ SAð Þik þ Eijkl
where Yijkl is the measure for the l
th individual of the ith
strain, jth diet from kth age group; Si indicates whether the
bird was RES or SUS; Ak represents the two age groups
i.e. 6-week or 12-week old; Dj indicates whether the bird
was on a regular diet or a cholesterol diet; (SD)ij and (SA)ik
are interaction terms; and Eijkl is the error term. The data
were log-transformed before analysis. The results were
reported as the least square mean values for each dataset ±
standard error of means (SEM) and the level of statistical
significance was defined at P< 0.05. Tukey’s HSD was used
for mean separation.
For plasma lipid parameters, the following model was
used:
Yijk ¼ μþ Si þ Dj þ SDð Þij þ Eijk
The mRNA levels of the seven candidate genes were
also regressed on the plasma lipid parameters with mul-
tiple regression analysis (JMP 8.0).
Results
The effects of strain and diet on the mRNA expression of
the seven genes examined are shown in Table 4. Because
none of the 6-week old birds were fed the cholesterol-
enhanced diet, we could examine the effects of strain and




The expression of HMGCR was significantly (P< 0.01)
higher in RES (1.08 ± 0.07 HMGCR/GAPDH) than in
SUS birds (0.82 ± 0.07 HMGCR/GAPDH), regardless of
dietary treatment and age (Table 4). No significant inter-
action effect was detected.FDFT1
The expression of FDFT1 was significantly (P< 0.04)
higher in RES (0.89 ± 0.11 FDFT1/GAPDH) than in SUS
birds (0.56 ± 0.11 FDFT1/GAPDH), regardless of dietary
treatment and age (Table 4). No significant interaction
effect was detected.
SQLE
The expression of SQLE was significantly (P< 0.02) higher
in RES than in SUS individuals when the birds were fed
the regular diet (Table 5), and its expression in both strains
was significantly (P< 0.01) suppressed when the birds
were fed the cholesterol diet (Table 4). However, the strain
x diet interaction was not significant (P= 0.51).
DHCR7
There were no strain differences (P= 0.35) in the expres-
sion of DHCR7 when the birds were fed the control diet
(Table 5). When challenged by the cholesterol diet, its ex-
pression was significantly (P< 0.04) higher in RES
(1.012±0.01 DHCR7/GAPDH) than in SUS birds
(0.673±0.01 DHCR7/GAPDH) (Table 4). However, the
strain x diet interaction was not significant (P= 0.6). Six-
week old birds (1.36 ± 0.18 DHCR7/GAPDH) had a
significantly (P< 0.01) higher DHCR7 expression than
12-week old birds (0.88 ± 0.10 DHCR7/GAPDH) (Table 5).
ATP-cassette binding transporter genes
ABCG5
There was a significant (P< 0.05) diet x strain interaction
in ABCG5 gene expression. When fed the regular diet,
expression of ABGC5 was significantly higher in RES than
in SUS birds. When challenged with the cholesterol diet,
the difference in expression level in the two strains be-
came non-significant (Table 4). There was a significant
(P< 0.0005) strain x age interaction for birds on the regular
diet (Table 5); the expression of ABCG5 significantly
increased with age in RES birds but not in SUS birds.
ABCG8
The expression of ABCG8 was significantly (P< 0.02)
higher in RES (1.50± 0.14 ABCG8/GAPDH) than in SUS
birds (0.97 ± 0.15 ABCG8/GAPDH) (Table 4). Birds fed
the cholesterol diet (1.59 ± 0.17 ABCG8/GAPDH) had sig-
nificantly (P< 0.002) higher ABCG8 expression than birds
on the control diet (0.88 ± 0.12 ABCG8/GAPDH) (Table 4).
Twelve-week old birds (1.38 ± 0.11 ABCG8/GAPDH) on
regular diet had a significantly (P< 0.004) higher ABCG8
expression than 6-week old birds (0.82 ± 0.19 ABCG8/
GAPDH) on the same diet (Table 5).
APOA1
There was no significant (P = 0.46) strain effect on the
expression of APOA1. Both RES and SUS birds fed the
Table 4 Liver mRNA expressions} in SUS and RES quail fed regular or cholesterol diets
Gene Effect Regular diet Cholesterol diet
RES (N= 13) SUS (N= 12) RES (N= 6) SUS (N= 6)
HMGCR *P< 0.01 1.059 ± 0.080 0.776 ± 0.080 1.082 ± 0.127 0.946 ± 0.127
FDFT1 *P< 0.04; †P< 0.02 1.220 ± 0.125 0.598 ± 0.125 0.563 ± 0.177 0.529 ± 0.177
DHCR7 1.209 ± 0.157 1.094 ± 0.157 1.012 ± 0.222a 0.673 ± 0.222b
SQLE †P< 0.01 1.782 ± 0.308 0.392 ± 0.320 0.044 ± 0.453 0.008 ± 0.453
ABCG5 *† P< 0.05 0.914 ± 0.088a 0.566 ± 0.092b 0.959 ± 0.130ab 1.064 ± 0.130a
ABCG8 *P< 0.01; †P< 0.001 1.153 ± 0.163 0.609 ± 0.169 1.856 ± 0.240 1.331 ± 0.240
APAO1 †P< 0.001 0.857 ± 0.097 0.785 ± 0.101 1.382 ± 0.143 1.412 ± 0.143
N=number of individuals measured; total number of individuals = 37; *denotes significant strain effect; †denotes significant diet effect; *†denotes significant strain
x diet interaction; }all values (± SEM) indicate the gene of interest relative to GAPDH (arbitrary units).
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nificantly (P< 0.001) higher expression compared to
birds fed the regular diet (0.82 ± 0.05 APOA1/GAPDH)
(Table 4). Twelve-week old birds (1.12 ± 0.07 APOA1/
GAPDH) on regular diet had a significantly (P< 0.0001)
higher APOA1 expression than 6-week old birds
(0.54 ± 0.07 APOA1/GAPDH) on the same diet (Table 5).Plasma total cholesterol and LDL levels
There was a significant strain x diet interaction for
plasma total cholesterol (P< 0.013) and LDL (P< 0.01)
levels. Plasma total cholesterol and LDL levels in SUS
and RES birds fed the regular diet were not different but
they were significantly (P< 0.0001) higher when the
birds were fed the cholesterol diet, with levels in SUS
birds significantly (P< 0.05) higher than those in RES
birds (Tables 6 and 7).Plasma triglyceride levels
There was a significant (P< 0.02) strain x diet inter-
action in plasma triglyceride levels. Plasma triglyceride
levels in SUS and RES birds fed the regular diet were not
different. When the birds were fed the cholesterol diet,Table 5 - Liver mRNA expressions} in 6-week old and 12-week
Gene Effect 6-week
RES (N= 7)
HMGCR *P< 0.02 1.110 ± 0.110
FDFT1 *P< 0.01 1.359 ± 0.217
DHCR7 †P< 0.01 1.423 ± 0.250
SQLE *P< 0.02 2.430 ± 0.483
ABCG5 *†P< 0.0005 0.594 ± 0.076b
ABCG8 *P< 0.01; † P< 0.01 0.724 ± 0.189
APAO1 †P< 0.0001 0.626 ± 0.093
N=number of individuals measured; total number of individuals = 25; *denotes sign
x age interaction; }all values (± SEM) indicate the gene of interest relative to GAPDHplasma triglyceride levels increased significantly
(P< 0.05) in SUS but not in the RES birds (Table 6).Plasma HDL levels and LDL/HDL ratio
There was a significant (P< 0.028) strain x diet inter-
action in plasma HDL levels. Plasma HDL levels were
significantly (P< 0.05) higher in SUS than in RES birds
when they were on the regular diet. Plasma HDL levels
did not change significantly when the birds were fed the
cholesterol diet; however, the difference between the
SUS and RES birds became non-significant (Table 7).
These small changes in the HDL level did not affect the
LDL/HDL ratio (see Table 8 and Table 7).Regression of gene expression on plasma lipid levels
Because regulation of gene expression may differ be-
tween the two strains, they were analysed separately
(Table 9). APOA1 expression regressed (r2 = 0.36) signifi-
cantly (P< 0.009) on plasma triglyceride level in the SUS
but not in the RES birds (Table 9, Figure 1A and C). In
RES birds, APOA1 expression tended (P< 0.06; r2 = 0.24)
to regress on LDL (Table 9, Figure 1D) and regressed sig-
nificantly (P< 0.04; r2 = 0.28) on the LDL/HDL ratio
(Figure 2).old SUS and RES quail fed the regular diet
old 12-week old
SUS (N= 6) RES (N= 6) SUS (N= 6)
0.688 ± 0.110 1.009 ± 0.110 0.864 ± 0.110
0.558 ± 0.217 1.082 ± 0.217 0.638 ± 0.217
1.359 ± 0.250 0.995 ± 0.250 0.829 ± 0.250
0.414 ± 0.522 1.026 ± 0.522 0.370 ± 0.522
0.547 ± 0.082b 1.288 ± 0.082a 0.586 ± 0.082b
0.531 ± 0.204 1.654 ± 0.204 0.687 ± 0.204
0.448 ± 0.101 1.126 ± 0.101 1.123 ± 0.101
ificant strain effect; †denotes significant age effect; *†denotes significant strain
(arbitrary units).
Table 6 Plasma total cholesterol levels* and triglyceride













Regular 7.45 ± 2.58 c 0.98 ± 0.32 B 6.15 ± 3.90 c 1.18 ± 0.48 B
Cholesterol 42.43 ± 1.98 a 3.32±0.24 A 24.11±4.21b 1.54 ± 0.52 B
Total number of individuals measured N= 56; P< 0.01 and P< 0.02,
respectively *total cholesterol means followed by different lower case letters
are significantly different by Tukey’s HSD; **plasma triglycerides means
followed by different capital letters are significantly different by Tukey’s HSD.
Table 8 Plasma LDL/HDL ratio in SUS and RES quail fed
regular or high cholesterol diets (N= 51; P< 0.0042)
Diet SUS RES
Regular 0.34 ± 0.43 c 0.42 ± 0.66 c
Cholesterol 7.16 ± 0.37 a 3.84 ± 0.71 b
*means followed by different letters are significantly different by Tukey’s HSD.
Table 9 Regression of gene expression on plasma lipid
levels
mRNA expression* SUS RES
HMGCR Plasma
triglyceride
P = 0.60 NS P= 0.94 NS
LDL P= 0.30 NS P= 0.39 NS
FDFT1 Plasma
triglyceride
P = 0.99 NS P= 0.26 NS
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(r2 = 0.48) significantly (P< 0.008) and positively on
plasma LDL level (Table 9, Figure 3), whereas DHCR7 and
SQLE expression regressed significantly (P< 0.04 and
P< 0.02, respectively) and negatively on plasma triglycer-
ide level (Table 9, Figures 4A and 5A).
No other significant regression of gene expression on
plasma lipid levels was found in the RES birds. However,
given the fact that only a few individuals showed high
levels of plasma lipid, a linear relation between gene
expression and plasma lipid levels may not be valid.
Examination of the regression plots revealed that in both
the SUS and RES birds, SQLE and FDFT1 expressions
were completely or drastically suppressed when plasma
triglycerides or LDL reached a threshold level (Figures 5
and 6). DHCR7 expression appears to follow the same
pattern (Figure 4).
Discussion
The RES and SUS quail strains have been developed
through divergent selective breeding from the same foun-
dation population [5], and thus should be genetically simi-
lar except for the changes induced by selection. Previously,
it has been reported that one of the observable differences
between RES and SUS individuals is that after being fed on
a cholesterol-enhanced diet, plasma cholesterol levels
remain elevated in SUS individuals significantly longer than
in RES individuals [5]. Since the liver plays a key role in
regulating cholesterol homeostasis by acting as the mainTable 7 Plasma LDL levels* (N=51; P< 0.01) and HDL
levels)** (N=56; P< 0.028) in SUS and RES quail fed










Regular 1.75 ± 2.03 c 5.25 ± 0.21 A 1.64 ± 3.07 c 3.96 ± 0.32 B
Cholesterol 32.82 ± 1.73 a 4.81 ± 0.16 AB 18.64 ± 3.32 b 4.75 ± 0.35 B
*plasma LDL means followed by different lower case letters are significantly
different by Tukey’s HSD; **plasma HDL means followed by different capital
letters are significantly different by Tukey’s HSD.site for lipid metabolism and bile salt formation, we have
focused our study on this organ and more specifically on
the expression in liver of several cholesterol biosynthesis
and transporting genes. Although gene expression is a
phenotype and not a genotype, it probably reflects more
directly genotypic changes than morphological or physio-
logical phenotypes.Strain differences in gene expression
ABCG8 expression was significantly higher in the liver of
RES as compared to SUS individuals under all dietary
conditions, while ABCG5 expression was higher only under
some dietary conditions. Evidence from both animal mod-
els and research on man supports the important role of
these two ABC transporters in the regulation of the
excretion of sterols from the liver via bile to prevent the
accumulation of dietary sterols [19]. In human, mutations
in either of these genes cause sitosterolemia, a disorder that
is characterized by intestinal hyper-absorption of all sterols
and impaired ability to excrete sterols into bile. Patients
develop tendon and tuberous xanthomas, accelerated
atherosclerosis, and premature coronary artery disease
[19–21]. Sitosterolemia is caused by an abnormal expres-
sion pattern of the ABC transporters (heterodimers of ster-
olin-1 and sterolin-2), which function as gatekeepers forLDL P= 0.71 NS P= 0.12 NS
DHCR7 Plasma
triglyceride
r2 =−0.23; P< 0.04 P = 0.80 NS
LDL P= 0.29 NS P= 0.63 NS
SQLE Plasma
triglyceride
r2 =−0.29; P< 0.02 P = 0.09 NS
LDL r2 =−0.25; P< 0.04 P = 0.16 NS
ABCG5 Plasma
triglyceride
P = 0.11 NS P= 0.47 NS
LDL r2 =+0.48; P< 0.008 P = 0.84 NS






Figure 1 APOA1 expression in SUS and RES liver relative to plasma triglyceride and LDL levels. In part A: r2 = +0.36; P< 0.009.
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in exon 8 of the ABCG5 gene causes premature termination
of translation resulting in a truncated and non-functional
sterolin-1 protein. It has also been reported that several
mutations in ABCG8 result in a truncated non-functional
protein [19,22]. Besides, another point mutation in the
human ABCG5 gene enhancing the ABCG5/8 pathway has
been shown to protect against atherosclerosis by increasing
cholesterol elimination in the bile and reducing plasma
cholesterol levels [23]. Furthermore, a study on the mouseFigure 2 APOA1 expression in RES liver relative to LDL/HDL
ratio. r2 = 0.28; P< 0.04.has shown that over-expression of ABCG5 and ABCG8
decreases diet-induced atherosclerosis, in association with
reduced liver and plasma cholesterol levels [20]. Another
study of a partially inbred strain of opossums (Monodelphis
domestica) with low levels of ABCG5 and ABCG8 expres-
sion was associated with an elevation in diet-induced VLDL
and LDL cholesterol [24]. In our study, the lower ABCG8
and ABCG5 expression in the SUS individuals may be atFigure 3 ABCG5 expression in SUS liver relative to plasma LDL












Figure 5 SQLE expression in SUS and RES liver relative to plasma triglyceride and LDL levels. In part A: r2 =−0.29; P< 0.02.








Figure 6 FDFT1 expression in SUS and RES liver relative to plasma triglyceride and LDL levels.
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this strain to diet-induced atherosclerosis [24].
In the RES birds, ABCG5 expression remained high
regardless of dietary treatment, whereas in the SUS birds,
an increased level of ABCG5 expression could be induced
by a cholesterol-enhanced diet. Selection for atheroscler-
osis susceptibility may have altered the regulation of the
ABCG5 gene in the RES strain. Studies on mice have pro-
vided evidence for the direct control of ABCA1, ABCG5,
and ABCG8 mRNA expression by the liver X receptor
(LXR) pathway. Indeed, in mice fed with a cholesterol-
enhanced diet, ABCA1, ABCG5, and ABCG8 mRNA
expressions were up-regulated [25,26]. Liver X receptors
and retinoid X receptors (RXR) form RXR/LXR heterodi-
mer transcription factors that act as intracellular sterol
sensors [27]. Accordingly, selection for atherosclerosis
resistance may not have altered the expression of ABCG5
but rather the expression of some of these receptor genes
[26,28,29] thus permitting expression of ABCG5 to remain
in an up-regulated state in the RES individuals. It would be
interesting to examine the expression of the LXR and RXR
genes in the two quail strains under similar and different
dietary conditions.
While we have measured the levels of plasma cholesterol
and triglycerides, we have not determined their intracellu-
lar levels. The LDL receptor gene is regulated by the sterolregulatory element-binding protein (SREBP) pathway via
negative feedback [30–32]. When intracellular cholesterol
levels are high, the LDL receptor gene is down-regulated
[31]. With fewer receptors, the liver takes up the LDL from
blood less efficiently, and as a result, plasma LDL levels in-
crease. It is possible that selection has altered the expres-
sion of the LDL receptor gene in the SUS and RES strains.
SUS individuals are less efficient in removing excess chol-
esterol from the liver, thus they may have a down-regu-
lated expression of the LDL receptor gene resulting in a
higher level of dietary cholesterol remaining in circulation.
Therefore, it would be relevant to examine the expression
of the LDL receptor gene in the two quail strains fed with
different diets.
The expression of three genes involved in cholesterol
biosynthesis, HMGCR, FDFT1 and SQLE, was found
lower in SUS than in RES birds, regardless of diet and
age. As a counteraction effect to the selective pressure
for susceptibility to atherosclerosis, natural selection may
have caused a permanent down-regulation of these genes
in the SUS individuals to decrease endogenous choles-
terol synthesis to maintain homeostasis. Apparently, this
mechanism to maintain homeostasis became ineffective
when the birds are fed a diet containing an extremely
high level of cholesterol. These mevalonate pathway
genes are also regulated by the intracellular cholesterol
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http://www.gsejournal.org/content/44/1/20via the SREBP pathway [31]. For example, HMGCR has
been shown to be regulated by sterol and non-sterol meta-
bolites derived from mevalonate in a negative feedback loop
[31,33,34]. Similar to HMGCR, FDFT1 and SQLE are tran-
scriptionally regulated via the SREBP pathway [25]. We
have also found that the expression level of some of these
genes regressed negatively on plasma LDL and triglyceride
levels. A very high level of plasma cholesterol is associated
with suppressed or strongly reduced expression of FDFT1,
SQLE and DHCR7. Although they may not be the primary
rate-limiting enzymes in cholesterol biosynthesis [24], sup-
pression of their expression may also be a protective action
to turn off the endogenous cholesterol synthesis.
Thus, it is reasonable to hypothesize that the high intra-
cellular cholesterol levels in the liver cells of the SUS birds
may be related to the sub-normal functioning of the trans-
porter genes ABCG8 and ABCG5. The down-regulation of
the mevalonate pathway genes may be an ineffective
attempt to normalize intracellular cholesterol levels in the
liver cells of the SUS birds.Conclusions
Cholesterol metabolism and transport are regulated by a
complicated gene system. The number of genes that we
have sampled in this study remains small and from a
single tissue, thus we cannot draw any conclusion on
how this gene system works or how this gene system has
been affected by selective breeding. However, the SUS
strain responded to selection in a short time (i.e. four
generations) and then reached a plateau, which is an in-
dication that only a few genes have been altered. Our
results do provide some explanation for the plasma
cholesterol levels remaining high for a significantly
longer time in the SUS males than in the RES males.
With the progress in micro-array technology and
transcriptome pyrosequencing [35], this quail model will
be useful to study the ramification effects of a few genes
in the complicated gene system that affects
atherosclerosis.Abbreviations
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